经全子宫切除术/双侧输卵管卵巢切除术治疗的术后残留子宫腺肉瘤：病例报告及文献复习。
The uterine adenosarcoma with postoperative residual in a woman treated by total abdominal hysterectomy/bilateral salpingo-oophorectomy: A case report and review of literature.
机构信息
Department of Radiation Oncology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Department of Pathology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
出版信息
Cancer Rep (Hoboken). 2023 Oct;6(10):e1891. doi: 10.1002/cnr2.1891. Epub 2023 Aug 17.
BACKGROUND
In patients with uterine adenosarcoma, a total abdominal hysterectomy (TAH) with bilateral salpingo-oophorectomy (BSO) is typically recommended as an initial treatment. There is no consensus on adjuvant therapies.
CASE
We report the case of a patient with uterine adenosarcoma with postoperative residual disease. We performed four courses of adjuvant chemotherapy, including Ifosfamide, Mesna, and Adriamycin, and whole pelvic radiation with a dose of 50.4 Gy/28 Fr.
CONCLUSION
A combination of chemotherapy and radiotherapy may be a promising treatment option for uterine adenosarcoma with postoperative residual disease.
背景
在患有子宫腺肉瘤的患者中，通常建议采用全子宫切除术（TAH）加双侧输卵管卵巢切除术（BSO）作为初始治疗方法。对于辅助治疗方法尚无共识。
病例
我们报告了一例子宫腺肉瘤术后残留疾病的患者。我们进行了四个疗程的辅助化疗，包括异环磷酰胺、美司钠和阿霉素，并进行了全盆腔放疗，剂量为 50.4Gy/28Fr。
结论
化疗和放疗的联合治疗可能是治疗术后残留子宫腺肉瘤的一种有前途的选择。
Zotero 插件